Partnership Benefits

As a clinical research organisation, we are looking to build relationships with local healthcare professionals to assist in identifying patients who may benefit from our clinical trials.

  • By partnering with Canopy Clinical, you can provide your patients’ access to innovative new treatments and contribute to advancing medicine
  • Our experienced clinical trial staff will ensure the referral process and management of your patient is smooth, compliant, and patient-focused
  • Our dedicated team manage everything on our end, so there is minimal disruption to your day-to-day operations

Our Values

Compassion
By respecting our clinical trial participants, clients, and each other, we foster a transparent and welcoming environment.
Connection
Through partnership and collaboration, we create a supportive and inclusive canopy community where everyone thrives.
Commitment
We are built on a culture of continuous improvement and maintaining the highest standards of safety and quality in our work. We take accountability for our actions, proactively address challenges and collaborate to find effective solutions.
Courage
True progress is made when we take bold steps. Our courage inspires us to innovate, embrace change, and make decisions that are sometimes difficult but always necessary for growth.

Areas of Expertise

As a rapidly growing clinical research organisation, we are always expanding our range of therapeutic and interventional areas. 

We are looking for partnering clinicians who have an interest in the following areas to help bring potential new treatments to patients: 

  • Metabolic disorders
  • Cardiovascular diseases 
  • Renal diseases 
  • Sexual health 
  • Combination vaccine studies 

Our Referral Process

We have made our referral process as simple as possible, so that you can focus on caring for your patients and not get bogged down in paperwork. Our referral forms and eligibility checklists are compatible with Best Practice and Medical Director.

To refer a participant, simply follow the steps below:

Identifying suitable participants
From a list of our studies, you will be able to identify potential participants for healthy or patient focused clinical trials.
Pre-screening and eligibility check
Once you have identified if your patient is eligible and referred them, a member of our participant recruitment team will contact them to run through a pre-screening call. If they are deemed eligible, they will be contacted for an in-person screening appointment.
Ongoing communication
Our research investigators will contact you to notify you if your patient has been successfully randomised in the study. Any adverse events or new medical conditions identified will also be communicated with you.

Frequently asked questions

How do I know my patient will be safe?

Participant safety and wellbeing is paramount at Canopy Clinical – prior to enrolment in any trial, your patient will be guided through the Informed Consent process, ensuring they have a clear and thorough understanding of potential risks, restrictions and activities involved in the trial to help them make an informed decision. 

Before a trial begins recruitment, it must be approved by an independent Human Research Ethics Committee (HREC), which ensures the study is scientifically valid and prioritizes participant well-being. HRECs in Australia abide by the National Statement on Ethical Conduct in Human Research, which is referenced in Therapeutic Goods Regulations. 

Throughout the trial, participants are closely monitored by healthcare professionals, and safety data is regularly reviewed.  

 

How will my patient's data and medical history be protected?

When sharing clinical trial data with authorised agencies, participant data is ‘de-identified’ and replaced with a participant ID or code – meaning that your patient’s personal details are not disclosed. This ensures that your patient’s information always remains confidential. 

Your patient’s personal contact details will only ever be used for the purpose of research at Canopy Clinical and will not be shared with any third parties without their explicit permission, except when required by law.

Will I receive communications/updates regarding my patient's progress?

As the primary doctor, it is critical you are informed of your patient’s progress on the clinical trial. Our clinical researchers will communicate with you at the following stages:  

  • At screening – if our screening process identifies any new medical conditions  
  • At randomisation – when your participant consents and is randomised on to the study 
  • Adverse events – if throughout the study any new allergies or notable side effects arise, you will be notified 
  • At completion of study – at the end of the study you will receive a final communication notifying you your patient is no longer on the study. 
What is your clinical leadership structure?

At Canopy Clinical, our clinical leadership framework is built on the expertise and insight of our Chief Medical Officer and our team of experienced clinical investigators. We believe that clinician-led decision making is critical for delivering high quality clinical research. 

Who is conducting this research?

Canopy Clinical is a site research network, conducting various clinical trials on behalf of different pharmaceuticals, biotechnology companies and contract research organisations. Our doctor information letters and materials for doctors will clearly state the sponsor of the study, and all relevant parties involved. 

Contact Us

Our participant recruitment and medical science liaison team is committed to ensuring the referral process is as smooth as possible. 

If you would like to discuss a particular clinical trial, or have questions about our referral process, please contact our Medical Science Liaison, Vanessa McCarthy-McIntyre.

You can do this via our ‘Contact Us’ form, or by getting in touch with our recruitment team for further information.

Clinician Database Sign Up

Interested in hearing about our current and upcoming clinical research for your patients?

Sign up to our clinician database to be the first in the know.